Cargando…

FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer

SIMPLE SUMMARY: Ovarian cancer is a lethal disease in women with a 10-year survival rate of <40% worldwide. A key molecular alteration in ovarian cancer is the aberrant overexpression and activation of the transcription factor forkhead box M1 (FOXM1). FOXM1 regulates the expression of a multitude...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Cassie, Barger, Carter J., Karpf, Adam R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235333/ https://www.ncbi.nlm.nih.gov/pubmed/34205406 http://dx.doi.org/10.3390/cancers13123065

Ejemplares similares

NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma
por: Haque, Moinul, et al.
Publicado: (2019)

Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer
por: Barger, Carter J, et al.
Publicado: (2019)

Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression
por: Barger, Carter J., et al.
Publicado: (2015)

Co-regulation and function of FOXM1/RHNO1 bidirectional genes in cancer
por: Barger, Carter J, et al.
Publicado: (2021)

Structural Insights in Multifunctional Papillomavirus Oncoproteins
por: Suarez, Irina, et al.
Publicado: (2018)

MYB oncoproteins: emerging players and potential therapeutic targets in human cancer
por: Cicirò, Ylenia, et al.
Publicado: (2021)

The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment
por: Mokhtari, Reza Bayat, et al.
Publicado: (2023)

PRAME expression and promoter hypomethylation in epithelial ovarian cancer
por: Zhang, Wa, et al.
Publicado: (2016)

FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases
por: Zhang, Zhenwang, et al.
Publicado: (2023)

The Fra-1/AP-1 Oncoprotein: From the “Undruggable” Transcription Factor to Therapeutic Targeting
por: Casalino, Laura, et al.
Publicado: (2022)

BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
por: Zhang, Zhenfeng, et al.
Publicado: (2016)

Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability
por: Zhang, Wa, et al.
Publicado: (2020)

Regulation of the master regulator FOXM1 in cancer
por: Liao, Guo-Bin, et al.
Publicado: (2018)

FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer
por: Zhou, Jinhua, et al.
Publicado: (2014)

DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer
por: Zhang, Wa, et al.
Publicado: (2015)

Targeting GRB7/ERK/FOXM1 Signaling Pathway Impairs Aggressiveness of Ovarian Cancer Cells
por: Chan, David W., et al.
Publicado: (2012)

Therapeutic DNA vaccination against colorectal cancer by targeting the MYB oncoprotein
por: Cross, Ryan S, et al.
Publicado: (2015)

Expression of the POTE gene family in human ovarian cancer
por: Barger, Carter J, et al.
Publicado: (2018)

Effect of taxol on the expression of FoxM1 ovarian cancer-associated gene
por: LIU, ZENG, et al.
Publicado: (2016)

The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival()
por: Hacker, Kari E, et al.
Publicado: (2018)

Small molecule targeting FOXM1 DNA binding domain exhibits anti-tumor activity in ovarian cancer
por: Zhang, Zaixin, et al.
Publicado: (2022)

A narrative review of research progress on FoxM1 in breast cancer carcinogenesis and therapeutics
por: Zhang, Yan-Ling, et al.
Publicado: (2021)

PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy
por: Kelm, Jeremy M., et al.
Publicado: (2023)

Targeting Oncoproteins for Molecular Cancer Therapy
por: Allen, Joshua E., et al.
Publicado: (2016)

Up-Regulation of FOXM1 by E6 Oncoprotein through the MZF1/NKX2-1 Axis Is Required for Human Papillomavirus–Associated Tumorigenesis()()
por: Chen, Po-Ming, et al.
Publicado: (2014)

Correction: Targeting GRB7/ERK/FOXM1 Signaling Pathway Impairs Aggressiveness of Ovarian Cancer Cells
Publicado: (2014)

Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer
por: Pyragius, Carmen E., et al.
Publicado: (2013)

FoxM1 and β-catenin predicts aggressiveness in Middle Eastern ovarian cancer and their co-targeting impairs the growth of ovarian cancer cells
por: Pratheeshkumar, Poyil, et al.
Publicado: (2017)

A multifunctional-targeted nanoagent for dual-mode image-guided therapeutic effects on ovarian cancer cells
por: Chen, Chunyan, et al.
Publicado: (2019)

Targeting Human Papillomavirus-Associated Cancer by Oncoprotein-Specific Recombinant Antibodies
por: Donà, Maria Gabriella, et al.
Publicado: (2021)

The cell-penetrating FOXM1 N-terminus (M1-138) demonstrates potent inhibitory effects on cancer cells by targeting FOXM1 and FOXM1-interacting factor SMAD3
por: Zhang, Zhenwang, et al.
Publicado: (2019)

CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer
por: Ring, Alexander, et al.
Publicado: (2018)

WD Repeat and HMG Box DNA Binding Protein 1: An Oncoprotein at the Hub of Tumorigenesis and a Novel Therapeutic Target
por: Zhang, Zhiwei, et al.
Publicado: (2023)

Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer
por: Katzenellenbogen, Benita S., et al.
Publicado: (2023)

FOXM1: An emerging master regulator of DNA damage response and genotoxic agent resistance
por: Zona, Stefania, et al.
Publicado: (2014)

FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer
por: Fan, Qipeng, et al.
Publicado: (2015)

Domatinostat Targets the FOXM1–Survivin Axis to Reduce the Viability of Ovarian Cancer Cells Alone and in Combination with Chemotherapeutic Agents
por: Nakagawa-Saito, Yurika, et al.
Publicado: (2023)

YB-1 as an Oncoprotein: Functions, Regulation, Post-Translational Modifications, and Targeted Therapy
por: Yin, Qiyan, et al.
Publicado: (2022)

FoxM1 is an independent poor prognostic marker and therapeutic target for advanced Middle Eastern breast cancer
por: Siraj, Abdul Khalid, et al.
Publicado: (2018)

The multifaceted roles of FOXM1 in pulmonary disease
por: Li, Yumei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gg731mgpvjnfjr2s0sdk932ipi